Last reviewed · How we verify

NCT03694613

Utility of Placental/Umbilical Cord Blood in Early Onset Neonatal Sepsis in Very Low Birth Weight Infants

Completed NA Results posted Last updated 10 August 2021
What this trial tests

NA trial testing Placental/Umbilical Cord Blood sample in Preterm Infant in 65 participants. Completed in 20 August 2020.

Timeline
1 June 2019
Primary endpoint
1 June 2020
20 August 2020

Quick facts

Lead sponsorThe University of Texas Medical Branch, Galveston
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment65
Start date1 June 2019
Primary completion1 June 2020
Estimated completion20 August 2020
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

The University of Texas Medical Branch, Galveston

Who can join

Under 1 Day, any sex, with Preterm Infant or Early-Onset Neonatal Sepsis. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

White Blood Cell Count (WBC) (1) Primary · Completed during the first 30 minutes after birth. This sample is going to be taken from the discarded Placental/umbilical blood cord.

Normal Range approximately 6,000 - 30,000 cell/mm3.

GroupValue95% CI
Placental/Umbilical Cord Blood Sample8257± 2966
White Blood Cell Count (WBC) (1) INFANT BLOOD Primary · Completed during the first 6 hours after birth. This sample is going to be taken directly from the participant.

Normal Range: 6.000 - 30.000 cell/mm3.

GroupValue95% CI
WBC- INFANT BLOOD7055± 12400
I/T Ratio (Immature/Total Immature Neutrophil).I/T Ratio Was Calculated by Dividing Immature White Cell Count Total White Cell Count Primary · Completed during the first 30 minutes after birth. This sample is going to be taken from the discarded Placental/umbilical blood cord.

Normal Range of I/T ratio: \<0.2.

GroupValue95% CI
Placental/Umbilical Cord Blood Sample0.09± 0.13
I/T Ratio (Immature/Total Immature Neutrophil Ratio) INFANT BLOOD Primary · Completed during the first 12 hours after birth. This sample is going to be taken directly from the participant.

Normal Range: \<0.2

GroupValue95% CI
I/T Ratio. INFANT BLOOD0.12± 0.13
CRP (C-Reactive Protein)(1) Primary · Completed during the first 30 minutes after birth. This sample is going to be taken from the discarded Placental/umbilical blood cord.

Normal Range: \< 10,000 ng/mL

GroupValue95% CI
Placental/Umbilical Cord Blood Sample413± 1229
CRP (C-Reactive Protein)(2) INFANT BLOOD Primary · Completed during the first 6 hours after birth. This sample was taken directly from the participant.

Normal Range: \<10.000ng/mL

GroupValue95% CI
CRP- INFANT BLOOD785± 1846
IL-6 (1) Primary · Completed during the first 30 minutes after birth. This sample is going to be taken from the discarded Placental/umbilical blood cord.

Normal Range: 0-10.2 pg/ml

PUCB
GroupValue95% CI
Placental/Umbilical Cord Blood Sample61.45± 392.7
INFANT BLOOD
GroupValue95% CI
Placental/Umbilical Cord Blood Sample45.36± 182.3
IL-6 (Interleukin-6) INFANTS BLOOD Primary · Completed during the first 6hours after birth. This sample is going to be taken directly from the participant.

Normal Range: \<100 pg/mL

GroupValue95% CI
IL-6 - INFANT BLOOD45.36± 182.3
Procalcitonin PUBC Primary · Within 30 minutes after delivery

Blood was taken from PUBC after delivery

GroupValue95% CI
Procalcitonin - PUBC185.9± 374
Procalcitonin Level Was Measured in the Blood From Placenta and From the Baby Within 6 Hours After Birth Primary · Procalcitonin Level was measured in the blood from placenta and in Infant's Blood (within 6 hours)

Procalcitonin levels

GroupValue95% CI
Procalcitonin - Infant's Blood131.4± 411.7
Number of Participants With Negative Blood Culture From Blood Drawn From Placenta and From Baby Within 6 Hours After Birth Primary · Blood sample drawn from placenta and from baby within 6 hours after birth.

Normal Range: Blood Culture Negative

GroupValue95% CI
Placental/Umbilical Cord Blood Sample65
Presepsin- PUBC Primary · First 30 min after birth

Presepsin level was measured in the blood drawn from placenta and from the baby within 6 hours after birth

GroupValue95% CI
PRESEPSIN- PUCB4.6± 1.6

Sponsor's own description

This study evaluates the utility of placental/umbilical cord blood (PUCB) to perform the baseline workup testing for EONS in Very Low Birth Weight Infants: CBC (Complete Blood Count) with differential, Immature/Total ratio (I/T ratio), and blood culture along with CRP and IL-6 levels. A cohort (63 subjects) of preterm infants will be recruited. All the participants will be evaluated for sepsis using placental/umbilical cord blood (PUCB) and subject blood sample during the first 12 hours of life (after birth).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Application of Umbilical Cord Blood for the Clinical Prevention and Treatment of Complications in Preterm Infants(Review).
    Xu L, Shuzhe X, Jie Y. · · 2026 · PMID 41021185 · DOI 10.1007/s12015-025-10988-4

Verify or expand the search:

Other recruiting trials for Preterm Infant

Currently open trials in the same condition.

Other The University of Texas Medical Branch, Galveston trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03694613.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing